EnSite Precision 2.1 Feasibility Study

Status Completed

Clinical Trial Summary

The objective is to demonstrate feasibility of new 'Magnetic Primary' catheter tracking algorithms within the Velocity Research Platform (VRP) by assessing the frequency of shift/drift during ablation compared to the current commercial EnSite Precision 2.0.1

The secondary objective is to evaluate catheter rendering in the VRP system.

Clinical Trial Description

This is an acute, multi-center, observational, prospective feasibility study with up to 80 patients at up to 5 centers in Europe.

Data will be simultaneously collected on both the EnSite Precision 2.0.1 and VRP mapping systems for the entire duration of the EP mapping and ablation procedure. This study will not require significant change to the current clinical workflow of the mapping and ablation procedure. The VRP operator will observe both displays in real-time and will enter extensive electronic annotations to the VRP data stream to facilitate retrospective analysis. Examples of annotations include drug administration, patient movement, and the introduction of devices such as an intracardiac Echography (ICE) catheter which are not visible on the EnSite mapping system.

If/when the VRP operator notices events which might be better understood with additional data, he/she might ask the physician to hold a catheter in a stable position for an extra few seconds and/or move the catheter to another position. Examples of such events include catheters appearing outside the 3D model and unrealistic catheter shapes on either display. Compliance with such requests is optional and subject to physician preference.

Retrospective data analysis will focus on characterization of the following:

- Occurence rates and potential causes for Shift and Drift.

- Frequency and severity of discrepancies between impedance and magnetic coordinates.

- Positions of catheters relative to the 3D model.

- Positions of catheters relative to each other, comparing to fluoroscopic images when available.

- Shapes of catheters on the research system as the catheters are moved to different locations.

- Final geometry apprearance on the VRP.

- Voltage and timing maps appearance on the VRP. ;

Study Design

Related Conditions & MeSH terms

Arrhythmias

Clinical Trial Details

NCT number	NCT03110146
Study type	Observational [Patient Registry]
Source	Abbott Medical Devices
Contact
Status	Completed
Phase
Start date	January 4, 2017
Completion date	February 1, 2019

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT03289429` - Antiarrhythmic and Cardioprotective Effects of Atorvastatin Versus Magnesium Sulfate in Cardiac Valve Replacement Surgery	Phase 4
Unknown status	`NCT01834872` - Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation	Phase 4
Withdrawn	`NCT01026961` - Safety of Phenylephrine Hydrochloride, Acetaminophen, Dimethindene Maleate Compared to Phenylephrine Hydrochloride Alone in Healthy Volunteers	Phase 1/Phase 2
Not yet recruiting	`NCT05994755` - Association Between Cardiac ARRHYTHMIAs and Glycemic Variability in Patient With Type 2 Diabetes Monitored Through FREEstyle Libre and Bluetooth Technology.
Not yet recruiting	`NCT06039176` - Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Completed	`NCT02598258` - Hemodynamic Effects of Dry Sauna Followed by Cold Water Immersion in Healthy Subjects	N/A
Withdrawn	`NCT02575534` - Acute Mechanical Response to Anti-arrhythmic Drug Therapy	N/A
Withdrawn	`NCT00580255` - Comparison Study of BNP and Thoracic Impedance Measurements on Arrhythmias	N/A
Completed	`NCT00751738` - Long Term Safety of 125 mg Per Day of Oral Azimilide in Patients With Implantable Cardioverter Defibrillator (ICDs)	Phase 3
Completed	`NCT02629445` - HIPACE High Frequency Low Energy Pacing to Terminate Fast Ventricular Arrythmias	N/A
Recruiting	`NCT04563091` - Potassium Kinetic During and After Hemodialysis and Potassium Profiling to Prevent Arrhythmias	N/A
Completed	`NCT00589849` - T-Wave Alternans in Acute Myocardial Infarction: An Evaluation of the Time of Testing on Its Prognostic Accuracy	N/A
Active, not recruiting	`NCT03121183` - Medico-economic Evaluation of Strategies for the Lead Extraction of Implantable Defibrillator and Pacemakers	N/A
Completed	`NCT02110004` - Picasso NAV High-Density Mapping Catheter for Signal Analysis of Complex Arrhythmias - First-In-Man	Phase 1
Completed	`NCT02045043` - Genetic Risk Assessment of Defibrillator Events	N/A
Recruiting	`NCT01717469` - Safety and the Effects of Isolated Left Ventricular Pacing in Patients With Bradyarrhythmias	Phase 4
Completed	`NCT00919568` - Monitoring Arrhythmia Patients (IMPACT)	N/A
Terminated	`NCT00124891` - Study Evaluating GAP-486 in Non-sustained Ventricular Tachycardia	Phase 2
Withdrawn	`NCT01651702` - Comparison of Carto Versus Ensite 3D Electroanatomical Mapping Systems for Arrhythmias Ablations	N/A
Completed	`NCT02565069` - Identification for the Treatment of Complex Arrhythmias	Phase 4

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.